top of page
![WY.jpg](https://static.wixstatic.com/media/b11210_1b429f7d93ac4a6bb4272d240a901f23~mv2.jpg/v1/fill/w_106,h_53,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/b11210_1b429f7d93ac4a6bb4272d240a901f23~mv2.jpg)
The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Wyoming in 2022.
![WY.png](https://static.wixstatic.com/media/b11210_8632da68c13c441ab05b2d729899c720~mv2.png/v1/fill/w_176,h_141,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/WY.png)
Economic
Output
$300M
Direct Jobs Supported by the Industry
264
Total Jobs Supported
849
State Total Vendor Relationships
22
State Total Vendor Spending
$19,919,896
Clinical
Trials
4
Investments at Clinical Trial Sites
$34,000
Clinical Trial Participants
8
Total Economic Impact of Clinical Trial Sites
$100,000
bottom of page